全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

刘松江教授运用桔杏消积方治疗肺癌经验
Prof. Liu Songjiang’s Experience in Treating Lung Cancer by Using Jiexing Xiaoji Prescription (桔杏消积方)

DOI: 10.12677/tcm.2025.145283, PP. 1902-1906

Keywords: 肺癌,中医认识,辨证论治,桔杏消积方,治疗经验
Lung Cancer
, Understanding of Traditional Chinese Medicine, Syndrome Differentiation and Treatment, Jiexing Xiaoji Prescription, Treatment Experience

Full-Text   Cite this paper   Add to My Lib

Abstract:

化疗、放疗及靶向治疗是西医治疗肺癌的主要方法,但患者的耐受性差、治疗后产生的不良反应等因素严重影响患者的生存质量。然而中医治疗肺癌可以合理的弥补此类不足,能够提高患者对放疗和化疗的耐受性,减轻其不良反应,增强人体的免疫力,降低恶性肿瘤转移与复发的风险,延长患者的生存时间。刘松江教授在运用桔杏消积方治疗肺癌方面,有着深刻的心得体会,认为肺癌形成的原因为痰、瘀、虚、毒在人体交结所致,而桔杏消积方的组方恰好符合肺癌的病理特点,在临床中以桔杏消积方为基础,根据患者当前的证候、所处疾病的阶段和体质进行加减化裁。笔者通过跟诊学习和对门诊典型病例的收集、整理、分析,总结刘松江教授运用桔杏消积方治疗肺癌的学术经验,以期为临床提供中医药治疗肺癌的经验与思路。
Chemotherapy, radiotherapy and targeted therapy are the main methods of Western medicine in the treatment of lung cancer, but the poor tolerance of patients and adverse reactions after treatment seriously affect the quality of life of patients. However, TCM treatment of lung cancer can reasonably make up for such deficiencies, improve patients’ tolerance to radiotherapy and chemotherapy, reduce their adverse reactions, enhance human immunity, reduce the risk of metastasis and recurrence of malignant tumors, and extend the survival time of patients. Professor Liu Songjiang has a profound experience in the treatment of lung cancer with Jiexing Xiaoji Prescription (桔杏消积方). He believes that the formation of lung cancer is caused by the intersection of phlegm, stasis, deficiency and poison in the human body, and the composition of Jiexing Xiaoji Prescription (桔杏消积方) is exactly in line with the pathological characteristics of lung cancer. In clinical practice, Jiexing Xiaoji Prescription (桔杏消积方) is used as the basis for the addition and subtraction of patients according to their current syndrome, disease stage and physique. The author summarized Professor Liu Songjiang’s academic experience in the treatment of lung cancer with Jiexing Xiaoji Prescription (桔杏消积方) through follow-up study and collection, sorting and analysis of typical outpatient cases, in order to provide clinical experience and ideas on the treatment of lung cancer with traditional Chinese medicine.

References

[1]  李翔, 高申. 1990-2019年中国居民肺癌发病、患病和死亡趋势分析[J]. 中国慢性病预防与控制, 2021, 29(11): 821-826.
[2]  张宁, 张家合, 刘理礼, 等. 原发性肺癌521例临床特点分析[J]. 现代肿瘤医学, 2013, 21(10): 2246-2248.
[3]  黄子菁, 林丽珠. 中医药辨治肺癌治疗相关不良反应的研究进展[J]. 世界临床药物, 2021, 42(5): 340-344.
[4]  徐亚萍, 胡元, 刘安家. 肺癌的病因病机与临床研究进展[J]. 山西中医, 2010, 26(8): 57-58.
[5]  骆文斌, 吴承玉. 肺癌病因病机研究[J]. 辽宁中医药大学学报, 2009, 11(3): 16-17.
[6]  蔡云, 陈远彬, 叶放, 等. 国医大师周仲瑛从癌毒理论辨治肺癌经验述要[J]. 中华中医药杂志, 2020, 35(6): 2879-2882.
[7]  田建辉. “正虚伏毒”为肺癌发病的核心病机[J]. 上海中医药杂志, 2016, 50(12): 10-14.
[8]  孙艾琳, 闫珺, 张文思, 陈晶, 刘松江. 刘松江教授治疗肺癌经验[J]. 吉林中医药, 2020, 40(3): 342-345.
[9]  虞跃跃, 俞瑶帅, 汪铱宇, 等. 黄芪多糖免疫调节和抗肿瘤作用机制研究新进展[J]. 世界中医药, 2023, 18(20): 2998-3003.
[10]  李杏英, 胡雪原, 李勇华, 等. 黄芪四君子汤及其化裁方临床与实验研究进展[J]. 中医研究, 2021, 34(4): 57-60.
[11]  任统伟, 袁航, 魏娜, 等. 四君子汤加减辅助化疗治疗中晚期肺癌的研究[J]. 临床医学, 2023, 43(4): 112-114.
[12]  季漪, 吴勉华. 山慈菇化学成分及其抗肿瘤作用机制研究进展[J]. 中华中医药学刊, 2018, 36(3): 596-598.
[13]  曹凯琪, 高晋生. 关于白花蛇舌草治疗恶性肿瘤的中西医理论基础研究进展[J]. 世界最新医学信息文摘, 2019, 19(93): 90-92, 100.
[14]  谭建福, 赵云, 周军. 半枝莲在治疗肿瘤中的临床应用及研究进展[J]. 医学综述, 2013, 19(24): 4442-4444.
[15]  杨晓慧. 薏苡仁为主治疗癌症术后及放疗、化疗后患者[J]. 中医杂志, 2011, 52(9): 796-796.
[16]  彭艳, 马雪曼. 活血化瘀法抗恶性肿瘤转移的研究[J]. 内蒙古中医药, 2022, 41(5): 145-147.
[17]  陈小春, 李志明, 江威. 活血化瘀法治疗肺恶性肿瘤血瘀状态的研究进展[J]. 江西中医药, 2023, 54(11): 76-79.
[18]  马海刚, 高宏, 王晓东. 活血化瘀药治疗恶性肿瘤伴高凝状态的用药规律及安全性研究[J]. 中国处方药, 2023, 21(10): 138-141.
[19]  易志忠, 陈国忠, 欧智海, 等. 基于“升降相因”探讨脏腑气机升降及药对配伍理论[J]. 中国中医基础医学杂志, 2021, 27(2): 228-229, 239.
[20]  张金艳, 何萍, 李贻奎. 苦杏仁、桔梗及二者配伍止咳、祛痰作用的研究[J]. 中国实验方剂学杂志, 2010, 16(18): 173-175.
[21]  陈苑林. 苦杏仁与桔梗止咳、平喘、祛痰的配伍比例和机制探讨[J]. 心理月刊, 2020, 15(5): 190.
[22]  林瑞婷, 陈芝强, 林丽珠. 基于网络药理学探讨桔梗-苦杏仁与肺癌相关分子机制[J]. 中国实验方剂学杂志, 2020, 26(19): 217-224.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133